Clinical studies recruiting near Zhongshan

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Coronary Aspiration Catheter Clinical Trial
NA · BrosMed Medical Co., Ltd · NCT06951724 Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC
Phase 3 · Eye & ENT Hospital of Fudan University · NCT06235203 Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients
NA · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07126470 A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit
Phase 2 · Jiangsu HengRui Medicine Co., Ltd. · NCT07372924 A Study to Assess the Adverse Events and How Intravenously Infused Livmoniplimab in Combination With Budigalimab Moves T
Phase 1 · AbbVie · NCT06487559 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Boehringer Ingelheim · NCT07355296 Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC
Phase 2 · Zhongshan City People's Hospital · Guangdong Association of Clinical Trials · NCT05536505 Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NA · Shanghai Gynecologic Oncology Group · NCT05236686 Impact of External Drainage of the Main Pancreatic Duct and Common Bile Duct on Pancreatic Fistula Following Pancreatico
NA · Shanghai Zhongshan Hospital · NCT06322680 A Study of MRG006A in the Treatment of Patients With Advanced Solid Tumors
Phase 1/Phase 2 · Lepu Biopharma Co., Ltd. · NCT07093970 A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
Phase 3 · Takeda · NCT06671496 A Phase I Clinical Study to Evaluate the PK Profile, Efficacy, Safety and Immunogenicity of HLX17 vs. Keytruda® in Multi
Phase 1 · Shanghai Henlius Biotech · NCT07160335 The Chinese Familial Alzheimer's Network
Phase N/A · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Capital Medical University · NCT03657732 QL1706（Iparomlimab/Tuvonralimab) Combined With Gemcitabine and Cisplatin as First-Line Treatment for PD-L1-Positive Bili
Phase 2 · Shanghai Zhongshan Hospital · NCT07733115 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov
Phase 3 · Amgen · NCT07037433 A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
Phase 2 · Eli Lilly and Company · NCT07483099 Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS
Phase 2 · Fudan University · NCT06218810 A Study of the Efficacy, Safety, and Pharmacokinetics (PK) of the Port Delivery System With Ranibizumab (PDS) in Chinese
Phase 3 · Hoffmann-La Roche · NCT05562947 A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopa
Phase N/A · Bristol-Myers Squibb · NCT07361289 Neoadjuvant Chemotherapy Combined With Sintilimab and Bevacizumab for TNBC (NEOTORCH-BREAST07)
Phase 2 · First Affiliated Hospital of Zhejiang University · NCT07351487 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · Zhongshan Peoples Hospital · Eli Lilly and Company · NCT06890598 GenSci143 in Participants With Advanced Solid Tumors
Phase 1 · Changchun GeneScience Pharmaceutical Co., Ltd. · NCT07252414 Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
Phase 2 · Hrain Biotechnology Co., Ltd. · NCT05436223 Assisting Pulmonary Disease Diagnosis With Ophthalmic Artificial Intelligence Technology
Phase N/A · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT05847894 Comparison of Low- Versus High-Level Angle Kappa Compensation Strategies in SMILE Using the VisuMax 800: A Randomized Cl
NA · Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07512102 Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes
EARLY_Phase 1 · Shanghai Zhongshan Hospital · NCT07528105 A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
Phase 1/Phase 2 · RemeGen Co., Ltd. · NCT07105215 A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer
Phase 2 · Suzhou Suncadia Biopharmaceuticals Co., Ltd. · NCT07450976 Clinical Trial Evaluating TQB6411 Injection in Participant s With Esophageal Cancer
Phase 1/Phase 2 · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · NCT07367516 ART Trial: Transcatheter J-VALVE Versus Surgery for Aortic Regurgitation Therapy
NA · Second Affiliated Hospital, Zhejiang University, School of M · NCT07453407

Look up another city

Look up another condition